Nitrosative stress but not glycemic parameters correlate with improved neuropathy in nonseverely obese diabetic patients after Roux-Y gastric bypass

Surgery for Obesity and Related Diseases

Volumn 11, Issue 4, 2015, Pages 847-854

  Müller Stich, Beat P ^a   Billeter, Adrian T ^a   Fleming, Thomas ^a   Fischer, Lars ^a   Büchler, Markus W ^a   Nawroth, Peter P ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Carbonyl stress; Diabetes; Gastric bypass; Metabolic surgery; Neuropathy; Oxidative stress; RYGB

Indexed keywords

3 NITROTYROSINE; CARBONYL DERIVATIVE; CARBOXYLATED LYSINE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LYSINE; METHYLGLYOXAL; ORAL ANTIDIABETIC AGENT; UNCLASSIFIED DRUG; 3-NITROTYROSINE; GLUCOSE BLOOD LEVEL; TYROSINE;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DRUG WITHDRAWAL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; NITROSATIVE STRESS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; ROUX Y ANASTOMOSIS; TREATMENT OUTCOME; ANALOGS AND DERIVATIVES; BLOOD; BODY MASS; COMPLICATION; DIET RESTRICTION; DISEASE COURSE; LAPAROSCOPY; METABOLISM; OBESITY, MORBID; PHYSIOLOGY; PROCEDURES; STOMACH BYPASS; WEIGHT REDUCTION;

BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DISEASE PROGRESSION; FASTING; FEMALE; GASTRIC BYPASS; HUMANS; LAPAROSCOPY; MALE; OBESITY, MORBID; OXIDATIVE STRESS; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TYROSINE; WEIGHT LOSS;

EID: 84938200799     PISSN: 15507289     EISSN: 18787533     Source Type: Journal    
DOI: 10.1016/j.soard.2014.12.007     Document Type: Article

References (30)

1. C.A. Abbott, R.A. Malik, E.R. van Ross, J. Kulkarni, and A.J. Boulton Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K Diabetes Care 34 2011 2220 2224
2. S. Tesfaye, L.K. Stevens, J.M. Stephenson, and et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study Diabetologia 39 1996 1377 1384
3. J. Partanen, L. Niskanen, J. Lehtinen, and et al. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus N Engl J Med 333 1995 89 94
4. P.J. O'Connor, and F. Ismail-Beigi Near-Normalization of Glucose and Microvascular Diabetes Complications: Data from ACCORD and ADVANCE Ther Adv Endocrinol Metab 2 2011 17 26
5. F. Ismail-Beigi, T. Craven, M.A. Banerji, and et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial Lancet 376 2010 419 430
6. A.M. Vincent, B.C. Callaghan, A.L. Smith, and E.L. Feldman Diabetic neuropathy: cellular mechanisms as therapeutic targets Nat Rev Neurol 7 2011 573 583
7. G. Hussain, S.A. Rizvi, S. Singhal, M. Zubair, and J. Ahmad Serum levels of TNF-alpha in peripheral neuropathy patients and its correlation with nerve conduction velocity in type 2 diabetes mellitus Diabetes Metab Syndr 7 2013 238 242
8. A. Ceriello, F. Mercuri, L. Quagliaro, and et al. Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress Diabetologia 44 2001 834 838
9. V.R. Drel, S. Lupachyk, H. Shevalye, and et al. New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha} Endocrinology 151 2010 2547 2555
10. I.G. Obrosova, J.G. Mabley, Z. Zsengeller, and et al. Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst FASEB J 19 2005 401 403
11. M.P. Wautier, P. Massin, P.J. Guillausseau, and et al. N(carboxymethyl)lysine as a biomarker for microvascular complications in type 2 diabetic patients Diabetes Metab 29 2003 44 52
12. S. Tsuzura, Y. Ikeda, T. Suehiro, and et al. Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes Metabolism 53 2004 297 302
13. A. Bierhaus, T. Fleming, S. Stoyanov, and et al. Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy Nat Med 18 2012 926 933
14. D.J. Tracey, M.A. Romm, and N.N. Yao Peripheral hyperalgesia in experimental neuropathy: exacerbation by neuropeptide Y Brain Res 669 1995 245 254
15. Y.J. Tsai, C.T. Lin, C.T. Huang, and et al. Neuropeptide Y modulates c-Fos protein expression in the cuneate nucleus and contributes to mechanical hypersensitivity following rat median nerve injury J Neurotrauma 26 2009 1609 1621
16. M. Coudore-Civiale, C. Courteix, M. Boucher, J. Fialip, and A. Eschalier Evidence for an involvement of tachykinins in allodynia in streptozocin-induced diabetic rats Eur J Pharmacol 401 2000 47 53
17. B.P. Muller-Stich, L. Fischer, H.G. Kenngott, and et al. Gastric bypass leads to improvement of diabetic neuropathy independent of glucose normalization - results of a prospective cohort study (DiaSurg 1 study) Annals of Surgery 258 2013 760 765 discussion 5-6
18. A. Ceriello, R. Assaloni, R. Da Ros, and et al. Effect of irbesartan on nitrotyrosine generation in non-hypertensive diabetic patients Diabetologia 47 2004 1535 1540
19. A. Ceriello, L. Quagliaro, B. Catone, and et al. Role of hyperglycemia in nitrotyrosine postprandial generation Diabetes Care 25 2002 1439 1443
20. A.C. Group, A. Patel, S. MacMahon, and et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 2008 2560 2572
21. A.M. Vincent, J.M. Hayes, L.L. McLean, and et al. Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1 Diabetes 58 2009 2376 2385
22. K.M. Haslbeck, E.D. Schleicher, U. Friess, and et al. N(epsilon)-Carboxymethyllysine in diabetic and non-diabetic polyneuropathies Acta Neuropathol 104 2002 45 52
23. R. Marfella, M. Barbieri, R. Ruggiero, and et al. Bariatric surgery reduces oxidative stress by blunting 24-h acute glucose fluctuations in type 2 diabetic obese patients Diabetes Care 33 2010 287 289
24. T. Himeno, H. Kamiya, K. Naruse, and et al. Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice Diabetes 60 2011 2397 2406
25. M.R. Rizzo, M. Barbieri, R. Marfella, and G. Paolisso Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition Diabetes Care 35 2012 2076 2082
26. M. Mokadem, J.F. Zechner, R.F. Margolskee, D.J. Drucker, and V. Aguirre Effects of Roux-en-Y gastric bypass on energy and glucose homeostasis are preserved in two mouse models of functional glucagon-like peptide-1 deficiency Mol Metab 3 2014 191 201
27. F. Rubino, M. Gagner, P. Gentileschi, and et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism Ann Surg 240 2004 236 242
28. P.T. Chao, L. Yang, S. Aja, T.H. Moran, and S. Bi Knockdown of NPY expression in the dorsomedial hypothalamus promotes development of brown adipocytes and prevents diet-induced obesity Cell Metab 13 2011 573 583
29. S.J. Lee, S. Verma, S.E. Simonds, and et al. Leptin stimulates neuropeptide Y and cocaine amphetamine-regulated transcript coexpressing neuronal activity in the dorsomedial hypothalamus in diet-induced obese mice J Neurosci 33 2013 15306 15317
30. H.G. Kenngott, G. Clemens, M. Gondan, and et al. DiaSurg 2 trial - surgical vs. medical treatment of insulin-dependent type 2 diabetes mellitus in patients with a body mass index between 26 and 35 kg/m2: study protocol of a randomized controlled multicenter trial - DRKS00004550 Trials 14 2013 183